Who owns G1 Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in G1 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of G1 Therapeutics stock

Who bought or sold G1 Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 2.0M $6.0M 2% Dec 2023
 View chart
Raymond James & Associates 803k $3.5M 42% Mar 2024
 View chart
D. E. Shaw & Co 496k $1.5M -2% Dec 2023
 View chart
Standard Life Aberdeen 424k $1.3M 100% Dec 2023
 View chart
Marshall Wace 360k $1.1M -30% Dec 2023
 View chart
Schonfeld Strategic Advisors 341k $1.0M 100% Dec 2023
 View chart
Jacobs Levy Equity Management 313k $955k -45% Dec 2023
 View chart
Bank of America Corporation 280k $852k -3% Dec 2023
 View chart
Jane Street 223k $679k 2041% Dec 2023
 View chart
Connor, Clark & Lunn Investment Management 192k $586k -6% Dec 2023
 View chart
Level Four Advisory Services 179k $545k -3% Dec 2023
 View chart
Two Sigma Investments 162k $494k 79% Dec 2023
 View chart
Man Group 147k $447k 100% Dec 2023
 View chart
Citadel Advisors 134k $408k -38% Dec 2023
 View chart
Two Sigma Advisers 133k $405k -39% Dec 2023
 View chart
FinTrust Capital Advisors 101k $435k 154946% Mar 2024
 View chart
Denali Advisors 86k $372k -29% Mar 2024
 View chart
Citigroup 86k $262k 13267% Dec 2023
 View chart
Franklin Street Advisors 83k $360k 0% Mar 2024
 View chart
Dimensional Fund Advisors 77k $234k 3% Dec 2023
 View chart
Curi Wealth Management 71k $216k 0% Dec 2023
 View chart
683 Capital Management 64k $195k 100% Dec 2023
 View chart
Virtu Financial 45k $136k 100% Dec 2023
 View chart
Beacon Pointe Advisors 44k $133k 2% Dec 2023
 View chart
Creative Financial Designs 41k $175k 15% Mar 2024
 View chart
Algert Coldiron Investors 39k $117k -44% Dec 2023
 View chart
Rsm Us Wealth Management 35k $152k 0% Mar 2024
 View chart
Jump Financial 34k $105k 100% Dec 2023
 View chart
Raymond James Financial Services Advisors 31k $136k -7% Mar 2024
 View chart
Millennium Management 31k $95k -97% Dec 2023
 View chart
Capstone Investment Advisors 27k $118k 9% Mar 2024
 View chart
GSA Capital Partners 26k $79k 34% Dec 2023
 View chart
Wells Fargo & Company 23k $69k 6% Dec 2023
 View chart
Advisor Group Holdings 22k $67k 16% Dec 2023
 View chart
Charles Schwab Investment Management 22k $66k 0% Dec 2023
 View chart
Cubist Systematic Strategies 21k $65k 0% Dec 2023
 View chart
T. Rowe Price Associates 18k $55k 0% Dec 2023
 View chart
Cambridge Investment Research Advisors 17k $73k 42% Mar 2024
 View chart
Squarepoint Ops 16k $50k 27% Dec 2023
 View chart
Financial Advocates Investment Management 15k $62k 12% Mar 2024
 View chart
Two Sigma Securities 14k $43k 100% Dec 2023
 View chart
Cutler 12k $1.0k 100% Mar 2024
 View chart
Goldman Sachs Group 12k $35k -30% Dec 2023
 View chart
Barclays 6.3k $19k 0% Dec 2023
 View chart
UBS Group 3.2k $9.7k 1393% Dec 2023
 View chart
CWM 1.5k $6.0k 0% Mar 2024
 View chart
Federated Investors 1.4k $4.3k -57% Dec 2023
 View chart
Rhumbline Advisers 967.00 $2.9k 0% Dec 2023
 View chart
Signature 910.00 $2.8k -98% Dec 2023
 View chart
Hanson McClain Advisors 750.00 $3.2k 0% Mar 2024
 View chart
Proequities 517.00 $2.2M 0% Mar 2024
 View chart
Advisory Services Network 500.00 $1.5k 100% Dec 2023
 View chart
Bnp Paribas Arbitrage, Snc 308.00 $1.3k 0% Mar 2024
 View chart
Jpmorgan Chase & Co 250.00 $763.000000 -97% Dec 2023
 View chart
Royal Bank of Canada 90.00 $0 0% Dec 2023
 View chart
ICA Group Wealth Management 50.00 $153.000000 100% Dec 2023
 View chart

Who sold out of G1 Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Simplex Trading Dec 2023 234k $712k
SG Americas Securities Sep 2023 38k $54k
Bank of New York Mellon Dec 2023 18k $54k
Ables, Iannone, Moore & Associates Dec 2023 4.7k $14k
Tortoise Investment Management Sep 2023 3.0k $4.3k
Parallel Advisors Sep 2023 50.00 $72.000000